European VOD Registry
A Multi-centre, Multinational, Prospective Observational Registry to Collect Safety and Outcome Data in Patients Diagnosed With Severe Hepatic Veno-occlusive Disease (VOD) Following Hematopoietic Stem Cell Transplantation (HSCT) and Treated With Defitelio®
Sponsor: European Society for Blood and Marrow Transplantation
This observational or N/A phase trial investigates Hepatic Veno-Occlusive Disease and is currently completed. European Society for Blood and Marrow Transplantation leads this study, which shows 13 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Nov 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
May 2019 — Nov 2019 [monthly]
Active Not Recruiting
-
Mar 2019 — May 2019 [monthly]
Active Not Recruiting
-
Aug 2018 — Mar 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Society for Blood and Marrow Transplantation
- Jazz Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Angers, France , Bergamo, Italy , Birmingham, United Kingdom , Bordeaux, France , Bristol, United Kingdom , Clermont-Ferrand, France , Florence, Italy , Genova, Italy , Lille, France , Limoges, France and 30 more locations